RESEARCH ARTICLE


Dermatologic Manifestations of the LEOPARD Syndrome



S. Cao, A.F. Nikkels*
Department of Dermatology, CHU - Sart Tilman, University of Liege, B-4000, Liege, Belgium


Article Metrics

CrossRef Citations:
4
Total Statistics:

Full-Text HTML Views: 801
Abstract HTML Views: 1356
PDF Downloads: 1341
Total Views/Downloads: 3498
Unique Statistics:

Full-Text HTML Views: 428
Abstract HTML Views: 862
PDF Downloads: 924
Total Views/Downloads: 2214



Creative Commons License
© Cao and Nikkels

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Department of Dermatology, CHU - Sart Tilman, University of Liège, B-4000, Liège, Belgium; Tel: +32 4 366 7232; Fax: +32 4 366 7234; E-mail: af.nikkels@chu.ulg.ac.be


Abstract

The LEOPARD syndrome is an exceptional autosomal dominant genetic disease with a missense mutation of the PTPN11 gene in more than 90% of the cases. The principal clinical manifestations include extensive lentiginosis, heart conduction abnormalities, hypertrophic obstructive cardiomyopathy, ocular hypertelorism, pulmonary stenosis, genital anomalies, mental retardation, growth retardation and deafness. A woman with a LEOPARD syndrome illustrates the progressive development of melanocytic nevi. In fact, the majority of lentigines are actually melanocytic nevi. Sequential digital dermoscopy evidences progressive growth of some melanocytic lesions. The ever-increasing number of melanocytic nevi in the LEOPARD syndrome is a risk factor for melanoma and full body photography and dermoscopy are recommended for follow-up.

Keywords: LEOPARD syndrome, melanocytic nevi, dysmorphism, lentiginosis, PTPN11.